Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Total Current Liabilities (2016 - 2025)

Macrogenics (MGNX) has disclosed Total Current Liabilities for 14 consecutive years, with $43.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 22.36% to $43.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.1 million through Dec 2025, down 22.36% year-over-year, with the annual reading at $43.1 million for FY2025, 22.36% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $43.1 million at Macrogenics, down from $44.5 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $74.6 million in Q4 2021, with the low at $39.0 million in Q2 2025.
  • Average Total Current Liabilities over 5 years is $54.6 million, with a median of $54.2 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities soared 52.36% in 2021, then crashed 34.82% in 2022.
  • Over 5 years, Total Current Liabilities stood at $74.6 million in 2021, then plummeted by 34.82% to $48.6 million in 2022, then grew by 15.42% to $56.1 million in 2023, then decreased by 1.03% to $55.5 million in 2024, then fell by 22.36% to $43.1 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $43.1 million, $44.5 million, and $39.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.